Literature DB >> 8635504

Retardation of phenotypic transition of rabbit arterial smooth muscle cells in three-dimensional primary culture.

M Yamamoto1, H Nakamura, M Yamato, M Aoyagi, K Yamamoto.   

Abstract

Three-dimensional gel culture systems represent conditions that mimic the differentiated state of mesenchymal cells in vivo. We examined gel contraction, cell growth, and phenotypic modulation of rabbit arterial SMC in three-dimensional gel culture. The gel contraction rate was dependent on the collagen type; that is, the contraction by freshly isolated SMC was faster and more pronounced in type I collagen than in type III collagen. In contrast, the phenotypic modulation of SMC was independent of collagen type. The major portion of cells in both type I and III collagens with growth factors underwent transition from a contractile (G0 phase) to a synthetic phenotype (G1B phase), but this transition was clearly delayed compared with that on collagens. The cells had hardly begun DNA synthesis in either collagen type and failed to proliferate even after 10 days of culture. These results indicate that collagen type is important in gel contraction by vascular SMC, while the organization of collagen fibrils (two-dimensional vs three-dimensional) is more critical in the phenotypic transition and proliferation of these cells. However, the more specific organization of extracellular matrix than the collagen gel culture system may be necessary to maintain the contractile phenotype of SMC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635504     DOI: 10.1006/excr.1996.0152

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  2 in total

1.  Effects of collagen gel configuration on behavior of vascular smooth muscle cells in vitro: association with vascular morphogenesis.

Authors:  J Song; B E Rolfe; I P Hayward; G R Campbell; J H Campbell
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-10       Impact factor: 2.416

Review 2.  Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy.

Authors:  Tracy A McGowan; Yanqing Zhu; Kumar Sharma
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.